Skip to main content
. 2010 Sep 27;50(3):437–449. doi: 10.1093/rheumatology/keq287

Fig. 1.

Fig. 1

Radiographic progression in early and established RA over 1 year of abatacept treatment. (A) Mean change from baseline in TS, ES and JSN at Year 1 of the AGREE trial for abatacept plus MTX- and MTX alone-treated patients [23]. Adapted from Westhovens et al. [23] copyright 2009, with permission from the BMJ Publishing Group Ltd. (B) Mean change from baseline in TS, ES and JSN at Year 1 of the AIM trial for abatacept- and placebo-treated patients [42]. ABA: abatacept; PBO: placebo. Adapted from Kremer et al. [42].